All Posts
WHO says it is monitoring a new Covid variant called ‘mu’.
3 Sep, 2021 | 10:21h | UTCWHO says it is monitoring a new Covid variant called ‘mu’ – CNBC
See also:
What’s the Mu variant? And will we keep seeing more concerning variants? – The Conversation
WHO monitoring new coronavirus variant named ‘Mu’ – France 24
New ‘mu’ coronavirus variant could escape vaccine-induced immunity, WHO says – LiveScience
WHO monitoring new coronavirus variant named Mu – The Guardian
[Preprint] Largest study of masks yet details their importance in fighting Covid-19.
3 Sep, 2021 | 10:30h | UTCLargest study of masks yet details their importance in fighting Covid-19 – NBC News
Original study: The Impact of Community Masking on COVID-19: A Cluster-Randomized Trial in Bangladesh – Innovations for Poverty Action
See also: A Study In Bangladesh Tripled The Rate Of Mask-Wearing. Can It Help In The U.S.? – NPR
Commentaries on Twitter (thread – click for more)
This is arguably the most important single piece of epidemiological research of the entire pandemic.
A MASSIVE randomized trial launched a pro-mask campaign in some Bangladeshi villages, but not others.
The result: masking villages got less COVID. https://t.co/8uKPXAvvnU
— Lyman Stone 石來民 🦬🦬🦬 (@lymanstoneky) September 1, 2021
(thread from the author – click for more)
Some misinterpretation of our #Bangladesh Mask RCT by those who don’t read research, which I’ll ignore, but also some parochial/racist reactions, which I must respond to https://t.co/FFeqz1zox5
— Mushfiq Mobarak (@mushfiq_econ) September 2, 2021
EU agency says to focus on vaccines first not booster shots.
3 Sep, 2021 | 10:34h | UTCEU agency says to focus on vaccines first not booster shots – Associated Press
See also: European officials say COVID-19 booster isn’t urgent – CIDRAP
Opinion | “The downsides of masking young students are real”.
3 Sep, 2021 | 10:24h | UTCThe Downsides of Masking Young Students Are Real – The Atlantic
Commentary with a rebuttal on Twitter (thread – click for more)
I'm not greatly interested in the school/mask debate, but I must say this is pretty wild – the article leads with this statement and then proceeds to offer no evidence whatsoever of any harms except "subjective [sic] shortness of breath" https://t.co/JL1Iadt8fy pic.twitter.com/5bZmvOhWo7
— Health Nerd (@GidMK) September 2, 2021
Review: Cardiovascular care of older adults.
3 Sep, 2021 | 10:13h | UTCCardiovascular care of older adults – The BMJ
AAP Guideline: Long-term follow-up care for childhood, adolescent, and young adult cancer survivors.
3 Sep, 2021 | 10:17h | UTCLong-term Follow-up Care for Childhood, Adolescent, and Young Adult Cancer Survivors – Pediatrics
Musculoskeletal complications following critical illness: A scoping review.
3 Sep, 2021 | 10:07h | UTC
Commentary on Twitter
Very pleased that our scoping review on MSK complications following critical illness has been published – first paper from my PhD! @mawilliamsinOx @helendawes2 @matthewjrowland @ouh_therapies @MOReS_OBU #icurehab https://t.co/f6kHDtMzrj pic.twitter.com/bOm3YvLP5U
— Owen Gustafson (@OxfordICUPhysio) August 26, 2021
Reimagining construction and renovation of health care facilities during emergence from a pandemic.
3 Sep, 2021 | 10:19h | UTC
RCT: In patients with Immune Thrombocytopenia, the addition of Mycophenolate Mofetil to a standard glucocorticoid regimen reduced refractory or relapsed disease but was associated with decreased quality of life outcomes regarding physical function and fatigue.
3 Sep, 2021 | 10:15h | UTC
Role of diagnostic imaging in psoriatic arthritis: how, when, and why.
3 Sep, 2021 | 10:05h | UTCRole of diagnostic imaging in psoriatic arthritis: how, when, and why – Insights into Imaging
Position Paper: Diagnosis and management of heart failure in elderly patients from hospital admission to discharge.
3 Sep, 2021 | 10:11h | UTC
Study casts doubt on WHO guidance on antibiotics for neonatal sepsis.
3 Sep, 2021 | 09:57h | UTCStudy casts doubt on WHO guidance on antibiotics for neonatal sepsis – CIDRAP
Invited commentary: Antibiotics for neonatal sepsis in low-income and middle-income countries—where to go from here? (free registration required)
Commentary on Twitter
"WHO recommends ampicillin in combination with gentamicin for the management of clinical neonatal sepsis; however, there are persistent concerns regarding antimicrobial resistance and therapeutic failures with this treatment" #PIDTwitter #IDTwitter #medtwitter #TwitteRx https://t.co/FDlXwugouU
— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) August 9, 2021
The Role of Lung Ultrasound in the Management of the Critically Ill Neonate—A Narrative Review and Practical Guide.
3 Sep, 2021 | 10:00h | UTC
Drowning in the literature? These smart software tools can help.
3 Sep, 2021 | 10:09h | UTCDrowning in the literature? These smart software tools can help – Nature
RCT: Baricitinib reduced mortality in hospitalized adults with COVID-19.
2 Sep, 2021 | 10:17h | UTCCommentaries:
Commentaries on Twitter
NEW—Baricitinib did not improve the composite primary endpoint of progression to NIV,
high-flow O2, IMV, or death; however, it did reduce 28-day all-cause mortality by 38·2% vs placebo (HR 0·57 [95% CI 0·41–0·78])Read the COV-BARRIER study: https://t.co/QrU6GW0XcQ#ISICEM2021
— The Lancet Respiratory Medicine (@LancetRespirMed) September 1, 2021
(thread – click for more)
1/🧵💥 NEW COVID THERAPY SAVES LIVES
Adding baricitinib to steroids will save 1,000s of hospitalized #COVID pts. Our @LancetRespirMed COV-Barrier study is FREE.
I explain👇why it’s such a great #Pandemic discovery story: a new way to ⬇️ COVID19 deaths.https://t.co/8I5BlwyT2R pic.twitter.com/6KcfQrljqC
— WesElyMD (@WesElyMD) September 1, 2021
Pro-Con Debate: 1- vs 2-Hour Fast for Clear Liquids Before Anesthesia in Children.
3 Sep, 2021 | 09:55h | UTC
Review | COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses.
2 Sep, 2021 | 10:06h | UTC
Commentary on Twitter
NEW REVIEW—COVID-19 and immune-mediated inflammatory diseases
Filippo Fagni and colleagues @UniFAU review the effect of disease and treatment on #COVID19 outcomes and #vaccine responseshttps://t.co/ue8XnDF1sM #LancetRheumatology @KorayTascilar pic.twitter.com/Yrk4SmeSbE
— The Lancet Rheumatology (@TheLancetRheum) August 27, 2021
Long COVID: the physical and mental health of children and non-hospitalized young people after SARS-CoV-2 infection – one in seven children may still have symptoms 15 weeks after infection.
2 Sep, 2021 | 10:10h | UTCCommentaries:
Long Covid in children ‘nowhere near scale feared’ – BBC
Related:
Cohort study: Risk factors for long covid in previously hospitalized children.
M-A: More than 50 long-term effects of COVID-19.
Commentary on Twitter (thread – click for more)
The worlds biggest study of post acute #COVID19 symptoms in children is out as a pre-print – the CLoCK study!
Fortunately results are very reassuring regarding symptom frequency and impact
Some important lessons, let's take a look 🧵
— Alasdair Munro (@apsmunro) September 1, 2021
Another study shows Pfizer mRNA vaccine immunity is reduced over time.
2 Sep, 2021 | 10:05h | UTCWaning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar – medRxiv
Related:
Studies: COVID vaccine protection waning against infection but not hospitalization.
Pfizer says it’s time for a Covid booster; FDA and CDC say not so fast.
Commentary on Twitter (thread – click for more)
The evidence of mRNA vaccine effectiveness (VE) waning grows: large Qatar experience shows substantial 5 month attrition for symptomatic infection VE below 50% and, to a lesser extent, vs hospitalization and deathhttps://t.co/4lIG68Bxm0 pic.twitter.com/rnyo0Si3RP
— Eric Topol (@EricTopol) August 27, 2021
Scientific Statement: Coronavirus Disease-2019 and Heart Failure.
2 Sep, 2021 | 10:08h | UTC
Commentary on Twitter
Released today: Coronavirus Disease-2019 and Heart Failure: A Scientific Statement from @HFSA, published in @JCardFail. @dranulala @ankeetbhatt @EricAdler17 @BhadeliaMD @AshishCorrea @ersied727 @heartofthemater @AndrewJSauer @NMHheartdoc @scottdsolomon https://t.co/fyWab32ruU pic.twitter.com/8pNY60I6gD
— HFSA (@HFSA) September 1, 2021
Recommendations for ventilation of indoor spaces to reduce COVID-19 transmission.
2 Sep, 2021 | 10:02h | UTCRelated:
We studied how to reduce airborne COVID spread in hospitals. Here’s what we learnt.
WHO: Roadmap to improve and ensure good indoor ventilation in the context of COVID-19
CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk
RCT: Among critically ill patients, targeting oxygenation to a low-normal range vs. high-normal range did not result in a reduction in organ dysfunction.
2 Sep, 2021 | 08:23h | UTCEffect of Low-Normal vs High-Normal Oxygenation Targets on Organ Dysfunction in Critically Ill Patients: A Randomized Clinical Trial – JAMA (free for a limited period)
Related:
M-A of randomized trials: Conservative oxygen therapy for critically ill patients.
Oxygen administration for patients with ARDS – Journal of Intensive Care
Commentary on Twitter
Multicenter RCT found, among critically ill patients, targeting oxygenation to a low-normal range compared with a high-normal range did not result in a statistically significant reduction in organ dysfunction https://t.co/lEq28bqmM4 #ISICEM21
— JAMA (@JAMA_current) August 31, 2021
EBM Learning | How to create PICO questions about diagnostic test. In this paper, the author presents an example of a PICO for a question about test accuracy and an example of a PICO for a question about the effects of care with a test.
2 Sep, 2021 | 08:18h | UTCHow to create PICO questions about diagnostic test – BMJ Evidence-Based Medicine
RCT: In patients with acute hypoxemic respiratory failure, a strategy of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal was not associated with improved outcomes.
2 Sep, 2021 | 08:21h | UTCEffect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial – JAMA (free for a limited period)
Related: Randomized Trial: Low vs Intermediate Tidal Volume Strategy in ICU Patients Without ARDS
Commentary on Twitter
In this randomized clinical trial that included 412 adults, 90-day mortality was 41.5% in the extracorporeal carbon dioxide removal group and 39.5% in the standard care group, a difference that was not statistically significant https://t.co/jhCY2r4qjX #ISICEM21
— JAMA (@JAMA_current) August 31, 2021
Treatment of urinary tract infections in infants <2 Months: A Living Systematic Review - short and long duration of parenteral antibiotics were associated with a similar risk of UTI recurrence.
2 Sep, 2021 | 08:19h | UTCTreatment of UTIs in Infants <2 Months: A Living Systematic Review – Hospital Pediatrics


